Top compounds associated with response to PLA2G4C


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.082 0.08
mRNA tivozanib CTRPv2 pan-cancer AAC -0.0066 0.9
mRNA tivozanib GDSC1000 pan-cancer AAC 0.0041 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC -0.0013 1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.041 0.2
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.041 0.3
mRNA triptolide CTRPv2 pan-cancer AAC -0.062 0.08
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.043 0.2
Download CSV